ARTICLE | Company News
Lilly, TransPharma in osteoporosis deal
June 13, 2008 1:20 AM UTC
TransPharma Medical (Lod, Israel) granted Eli Lilly (NYSE:LLY) exclusive, worldwide rights to develop and commercialize ViaDerm-hPTH (1-34) for osteoporosis. TransPharma will receive $35 million up fr...